Publications by authors named "Monica M Mita"

45Publications

Bromodomain inhibitors a decade later: a promise unfulfilled?

Br J Cancer 2020 Dec 29;123(12):1713-1714. Epub 2020 Sep 29.

The Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article and Find Full Text PDF
December 2020

PARP Inhibition in Cancer: An Update on Clinical Development.

Target Oncol 2019 12;14(6):657-679

Division of Medical Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article and Find Full Text PDF
December 2019

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas.

Oncotarget 2017 Oct 30;8(49):86769-86783. Epub 2017 Sep 30.

University of Arizona Cancer Center and Department of Medicine, Division of Translational and Regenerative Medicine, University of Arizona, Tucson, AZ, USA.

View Article and Find Full Text PDF
October 2017

Statins and pancreatic cancer.

Oncol Lett 2017 Mar 4;13(3):1035-1040. Epub 2017 Jan 4.

Experimental Therapeutics Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

View Article and Find Full Text PDF
March 2017

Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity.

World J Methodol 2016 Mar 26;6(1):25-42. Epub 2016 Mar 26.

Jun Gong, Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA 91010, United States.

View Article and Find Full Text PDF
March 2016

Targeting Survivin Inhibits Renal Cell Carcinoma Progression and Enhances the Activity of Temsirolimus.

Mol Cancer Ther 2015 Jun 25;14(6):1404-13. Epub 2015 Mar 25.

Division of Hematology/Oncology, Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, Texas.

View Article and Find Full Text PDF
June 2015

Pharmacokinetic study of aldoxorubicin in patients with solid tumors.

Invest New Drugs 2015 Apr 12;33(2):341-8. Epub 2014 Nov 12.

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite MS31, Los Angeles, CA, 90048, USA,

View Article and Find Full Text PDF
April 2015

Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel.

Cancer Chemother Pharmacol 2014 Dec 12;74(6):1113-24. Epub 2014 Oct 12.

Institute for Drug Development, Cancer Therapy and Research Center at UTHSCSA, University of Texas Health Science Center San Antonio, 4th Floor, Zeller Building, 7979 Wurzbach Road, San Antonio, TX, 78229, USA,

View Article and Find Full Text PDF
December 2014

Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells.

Front Oncol 2014 26;4:167. Epub 2014 Jun 26.

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles, CA , USA.

View Article and Find Full Text PDF
July 2014

Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.

Expert Rev Clin Pharmacol 2013 Sep 23;6(5):465-82. Epub 2013 Aug 23.

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article and Find Full Text PDF
September 2013